AbelaDrug200

N/A

Report date: 2023/02/12 00:15:33
NME

Base Information

Drug NameAbelaDrug200
Drug Alias NameAbelaDrug200
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCraniocerebral Trauma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbela Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbela Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCraniocerebral Trauma

Other Information

ATC CodeN/A
Related LinksN/A